IL-17D Polyclonal Antibody
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Application ![]()
| IHC-P |
---|---|
Primary Accession | Q8TAD2 |
Reactivity | Human |
Host | Rabbit |
Clonality | Polyclonal |
Calculated MW | 21893 Da |
Gene ID | 53342 |
---|---|
Other Names | Interleukin-17D (IL-17D) (Interleukin-27) (IL-27) |
Dilution | IHC~~IHC-p 1:50-200, ELISA 1:10000-20000 |
Format | Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.09% (W/V) sodium azide. |
Storage Conditions | -20℃ |
Name | IL17D |
---|---|
Function | Induces expression of IL6, CXCL8/IL8, and CSF2/GM-CSF from endothelial cells. |
Cellular Location | Secreted. |
Tissue Location | Expressed preferentially in adipose, skeletal muscle and CNS. |

Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Induces expression of IL6, CXCL8/IL8, and CSF2/GM-CSF from endothelial cells.

If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.